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Objective 
Renal injury secondary to Hepatitis C virus (HCV) and Human 
immunodeficiency virus (HIV) infections is nowadays well recognized and 
has an important impact on patients outcome and their survival. However, the 
long-term outcome of HCV- and HIV-associated nephropathies remains ill-
defined. The present work aims to characterise the pathological pattern and 
clinical data and to evaluate prognosis of HCV and HIV infected and co-
infected patients submitted to renal biopsy. 
Methods 
The present work is a retrospective review of all renal biopsies of HIV and/or 
HCV infected patients received in our laboratory, between January 2003 and 
December 2012. Tissues for optical microscopy were stained with 
haematoxylin-eosin, periodic acid Schiff, Masson’s trichrome, methenamine 
silver and Congo red. Immunofluorescence was performed in frozen sections, 
using IgA, IgG, IgM, C1q, C3, C4, kappa and lambda light chains and 
fibrinogen. Indirect immunofluorescence using formalin-fixed paraffin 
embedded section was performed when no frozen fragment was available. 
Every case was submitted to ultrastructural evaluation. 
Clinical and laboratory data were obtained. 
Chi-square test, t-test and Mann-Whitney were used when required. Statistics 
were performed with SPSS 20.0. 
Results 
In 390 biopsies registered in our laboratory between January 2003 and 
December 2012, 27 corresponded to HIV, 19 to HCV infected patients, 5 of 
them being HIV-HCV co-infected. Four patients were excluded because of 
insufficient clinical and/ or inadequate pathological sample. 41 biopsies were 
analised, corresponding to 39 patients. 
Mean age 47.9years (SD12.9), 75,6% men and 51,2% Caucasian. 82.5% of the 
HIV infected patients had AIDS.  
The clinical data and histological patterns of each groups are detailed in table 
1 and table 2, respectively.  
55,6% of HIV infected patients and 42.9% of HCV infected patients became 
dependent on  hemodialysis (p>0.05). Renal survival median time was 532.8 
days (+/- 850.2) for HIV infected patients and 693.1 days (+/- 965.0) for HCV 
infected patients. The HIV-HCV co-infected patients had the lowest  renal 
survival median time- 137.8 days (+/- 200.7). In a logistic regression model, 
the grade of interstitial fibrosis and tubular atrophy in the renal biopsy and 
creatinine at time of admission were associated (p<0.005) with progression to 
dialysis. 
The mortality reached 31.8% for HIV infected patients and 28.6% for HCV 
patients. The survival time was 1092.2 days (+/- 1099.8) for HIV infected 
patients and was 1014.9 (+/- 964.3) for HCV infected patients. (p>0.05)  
Conclusion 
As in others studies, HIV-associated nephropathy (HIVAN) was the 
predominant lesion in HIV infected patients. (figures 5 to 8) As documented in 
the literature, the strongest association with HCV is that of 
membranoproliferative glomerulonephritis (MPGN) and  the majority of cases 
had concomitant clinical features of mixed cryoglobulinemia; in the present 
work, the 4 HCV infected patients with MPGN had cryoglobulinemia. (figures 
1 to 4) Other renal lesions that are associated with HCV and HIV infections 
have been documented in several papers: membranous glomerulonephritis, 
IgA nephropathy, focal segmental glomerulosclerosis (FSGS), fibrillary 
glomerulonephritis and immunotactoid glomerulopathy, postinfectious 
glomerulonephritis and lymphoma in HCV infected patients; thrombotic 
microangiopathy, immune-complex glomerulonephritis, tubulointersticial 
nephropathy, FSGS and lymphoma in HIV infected patients. On the other 
hand, the introduction of combined anti-retroviral therapy changed the 
spectrum of renal disease in HIV infected patients, reducing the incidence of 
HIVAN and increasing diabetic nephropathy, hypertension and nephrotoxicity. 
HIV infected patients have a worse renal survival and higher mortality when 
compared with HCV infected patients. 
Patients infected with HIV and HCV can develop diverse renal pathologies. 
No correlations between clinical data and pattern of renal disease have been 
seen and it seems that is not possible to predict the renal disease based on 
clinical criteria alone. Renal biopsy remains the gold standard for establishing 
the diagnosis and can help predict renal prognosis.  
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Histological features of infected patients 
HCV 
infected 
patients 
(n=14) 
HIV 
infected 
patients 
(n=22) 
HIV-HCV 
co-infected 
patients 
(n=5) 
Mesangio-proliferative 
GN 
1 1 1 
Membranoproliferative 
GN 
4 (28.6%) 1 
GN proliferative 
extracapillary 
1 
GN membranous  1 
FSGS/ HIVAN 3 12 (54.5%) 1 
Chronic 
glomerulopathy n.o.s. 
2 
Tubulointersticial 
nephritis 
1 2 
Cast nephropathy 1 
Diabetic nephropathy 2 2 1 
Amyloidosis 1 
Lymphoma 1 2 
Intersticial fibrosis and 
tubular atrphy 
none/mild/moderate 
4 / 4/  6 3 / 7 / 12 0 / 2 / 3 
Clinical characteristics of infected patients 
HCV infected 
patients 
(n=19) 
HIV infected 
patients 
(n=27) 
Gender (%) 
Male 
Female 
 
66.7% 
 
77.8% 
Race (%) 
Caucasian race 
Black race 
 
72.2% 
 
52.3% 
Age 46.2 (+/-12.1) 49.5 (+/- 12.9) 
Diabetes Mellitus (%) 16.7%  (n=3) 18.5% (n=5) 
HIV infection (%) 
HCV infection 
Hepatitis B virus 
infection  
HIV-HBV infection 
HBV-HCV infection 
26.3% (n=5) 
 
15,8% (n=3) 
 
5.3% (n=1) 
 
 
 
18.5% (n=5) 
7.4% (n=2) 
 
 
3.7% (n=1) 
Cryoglobulin (%) 26.3% (n=5) - 
Serum creatinine (mg/dl) 5.3 (SD4.6) 4.3 (SD 2.6) 
Proteinuria (g) 15.86 (SD 49.2) 4.67 (SD 4.5) 
Haematuria (%) 63.8% 74.1% 
Renal replacement 
therapy (%,, p<0.05) 
42.9% 55.6% 
MPGN in a HCV infected patients with cryoglubolinemia: glomerulus with accentuated 
lobulation of tuft architecture, mesangial hipercellularity, some accumulation of eosinophilic 
material in capillary lumen and wall (fig.1 – haematoxylin-eosin, 20x), endothelial cell swelling 
with duplication of capillary basement membrane (fig.2 - methenamine silver, 40x). Mesangial 
and capillary wall deposition of C3 is demonstrated by immunofluorescence (fig.3) and on 
electron microscopy of formalin fixed sample (fig.4).  
Fig.1 Fig.2 
Fig.3 
Fig.4 
Fig.5 Fig.6 Fig.7 
Fig.8 
HIVAN in a HIV infected patient: a combined glomerular and tubular injury that is characterized 
by a collapsing glomerulopathy (fig.5- haematoxylin-eosin, 20x and fig.6- methenamine silver, 
20x), microcystic transformation of renal tubules and concomitant intersticial inflammation and 
fibrosis (fig.7- methenamine silver, 10x). Some tubuloreticular inclusions were highlighted by 
electron microscopy. (fig8) 
